Literatur
- 1
Crystal H A, Dickson D W, Lizardi J E, Davies P, Wolfson L I.
Antemortem diagnosis of diffuse Lewy body disease.
Neurol.
1990;
40
1523-1528
- 2
Litvan I, Agid Y, Goetz C, Jankovic J, Wenning G K, Brandel J P. et al .
Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic
study.
Neurol.
1997;
48 (1)
119-125
- 3
McKeith I G. et al .
Consensus guidelines for the clinical and pathological diagnosis of dementia with
Lewy bodies (DLB).
Neurol.
1996;
47
1113-1124
- 4
Wenning G K, Litvan I, Jankovic J, Granata R, Mangone C A, McKee A. et al .
Natural history and survival of 14 patients with corticobasal degeneration confirmed
at postmortem examination.
J Neurol Neurosurg.
Psychiatry1998;
64 (2)
184-189
- 5 Clough C G, Blockley A. Parkinson's disease and related disorders. In: Voltz R,
Bernat JL, Borasio GD et al. (Hrsg): Palliative care in neurology. Oxford, New York:
Oxford University Press 2004: 48-58
- 6
Wenning G K, Michlmayr S, Braune S, Brücke T, Fogal W, Gerster P. et al .
Empfehlungen zur Differenzialdiagnose von Parkinson-Syndromen.
Akt Neurol.
2001;
28
256-260
- 7 Oertel H W, Schulz J B. Parkinson-Syndrome. In: Brandt T, Dichgans J, Diener HC
(Hrsg). Therapie und Verlauf neurologischer Erkrankungen. Stuttgart: Kohlhammer 2003:
919-963
- 8 Poewe W, Wenning G K. Atypische Parkinson-Syndrome. In: Brandt T, Dichgans J, Diener
HC (Hrsg). Therapie und Verlauf neurologischer Erkrankungen. Stuttgart: Kohlhammer
2003: 964-982
- 9
McKeith I G, Perry E K, Perry E H.
Report of the second dementia with Lewy body international workshop.
Neurol.
1999;
53
902-905
- 10
McKeith I G, Ballard C G, Perry R H. et al .
Prospective validation of consensus criteria for the diagnosis of dementia with Lewy
bodies.
Neurol.
2000a;
54
1050-1058
- 11
McKeith I G, Del Ser T, Spano P. et al .
Efficacy of rivastigmine in dementia with Lewy bodies: a randomized, double-blind,
placebo-controlled international study.
Lancet..
2000b;
356
2031-2036
- 12
Schrag A, Ben-Shlomo Y, Quinn N P.
Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional
study.
Lancet.
1999;
354
1771-1775
- 13
Williams D R, deSilva R, Paviour D C. et al .
Characteristics of two distinct clinical phenotypes in pathologically proven progressive
supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
Brain.
2005;
128
1247-1258
- 14
Wenning G K, Ben Shlomo Y, Magalhaes M, Daniel S E, Quinn N P.
Clinical features and natural history of multiple system atrophy. An analysis of 100
cases.
Brain.
1994;
117
835-845
- 15
Wüllmer U, Klockgether T.
Klinik und Therapie der Multisystematrophie. Dt.
Ärztebl.
2003;
7
408-415
- 16
Shoji M, Harigaya Y, Sasaki A, Ueda K, Ishiguro K, Matsubara E, Watanabe M, Ikeba M,
Kanai M, Tomidokoro Y, Shizuka M, Amari M, Kosaba K, Nakazato Y, Okamoto K, Hirai S.
Accumulation of NACP/alpha-synuclein in Lewy body disease and multiple system atrophy.
J Neurol Neurosurg Psych.
2000;
68
605-608
- 17
Wenning G K, Ben-Shlomo Y, Hughes A, Daniel S E, Lees A, Quinn N P.
What clinical features are most useful to distinguish definite multiple system atrophy
from Parkinson's disease?.
J Neurol Neurolsurg Psychiat.
2000;
68
434-440
- 18
Gilman S, Low P A, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C J. et al .
Consensus statement on the diagnosis of multiple system atrophy.
J Auton Nerv Syst.
1998;
74
189-192
- 19
Riley D E, Lang A E, Lewis A, Resch L, Ashby P, Hornykiewicz O. et al .
Cortical-basal ganglionic degeneration.
Neurol.
1990;
40
1203-1212
- 20
Grimes D A, Lang A E, Bergeron C B.
Dementia as the most common presentation of cortical-basal ganglionic degeneration.
Neurol.
1999;
53
1969-1974
- 21
Graham N L, Bak T H, Hodges J R.
Corticobasal degeneration as a cognitive disorder.
Mov Disord.
2003;
18
224-232
- 22
Kertesz A, Martinez-Lage P, Davidson W, Munoz D G.
The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal
dementia.
Neurol.
2000;
55
1368-1375
- 23
Hallervorden J, Spatz H.
Eigenartige Erkrankung im extrapyramidalen System mit besonderer Beteiligung des Globus
pallidus und der Substantia nigra.
Z Gesamte Neurol Psychiatr.
1922;
79
254-302
- 24
Halliday W.
The nosology of Hallervorden-Spatz disease?.
J Neurol Sci.
1995;
134
Suppl: 84-91
- 25
Shevell M.
Racial hygiene, active euthanasia, and Julius Hallervorden.
Neurol.
1992;
42
2214-2219
- 26
Shevell M.
Hallervorden and History.
N Engl J Med.
2003;
348
3-4
- 27
Kreutzberg G W.
Betroffen von der Erbarmungslosigkeit.
Max-Planck-Spiegel.
1990;
4
33-35
- 28
Hallervorden J.
Über eine Kohlenmonoxydvergiftung im Fetalleben mit Entwicklungsstörung der Hirnrinde.
Allg Z Psychiatr.
1949;
124
289-298
- 29
Madhavi T, Jankovic J.
Neurodegenerative disease and iron storage in the brain.
Curr Opin Neurol.
2004;
17
437-442
- 30
Hayflick S J, Westaway S K, Levinson B. et al .
Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.
N Engl J Med.
2003;
348
333-340
- 31 Gasser T. Chorea. In: Brandt T, Dichgans J, Diener HC (Hrsg). Therapie und Verlauf
neurologischer Erkrankungen. Stuttgart: Kohlhammer 2003: 1040-1048
- 32
Reuter I, Hu M TM, Andrews T C, Brooks D J, Clough C, Chaudhuri K R.
Late onset levodopa responsive Huntington's disease with minimal chorea masquerading
as Parkinson plus syndrome.
J Neurol Neurosurg Psychiatr.
2000;
68
238-241
- 33
Di Maria E, Tabaton M, Vigo T, Abbruzzese G, Bellone E, Donati C. et al .
Corticobasal degeneration shares a common genetic background with progressive supranuclear
palsy.
Ann Neurol.
2000;
47
374-377
Prof. Dr. W. Nacimiento
Chefarzt der Neurologischen Klinik Klinikum Duisburg
Zu den Rehwiesen 7 - 9
47055 Duisburg
Email: w.nacimiento@t-online.de
